Natera Additional Paid-in Capital 2014-2025 | NTRA

Natera additional paid-in capital from 2014 to 2025. Additional paid-in capital can be defined as the excess over par value paid for common securities.
  • Natera additional paid-in capital for the quarter ending March 31, 2025 was $3.875B, a 19.54% increase year-over-year.
  • Natera additional paid-in capital for 2024 was $3.764B, a 19.64% increase from 2023.
  • Natera additional paid-in capital for 2023 was $3.146B, a 18.05% increase from 2022.
  • Natera additional paid-in capital for 2022 was $2.665B, a 29.96% increase from 2021.
Natera Annual Additional Paid-in Capital
(Millions of US $)
2024 $3,764
2023 $3,146
2022 $2,665
2021 $2,050
2020 $1,411
2019 $977
2018 $607
2017 $473
2016 $453
2015 $436
2014 $9
2013 $3
Natera Quarterly Additional Paid-in Capital
(Millions of US $)
2025-03-31 $3,875
2024-12-31 $3,764
2024-09-30 $3,393
2024-06-30 $3,320
2024-03-31 $3,241
2023-12-31 $3,146
2023-09-30 $3,089
2023-06-30 $2,796
2023-03-31 $2,742
2022-12-31 $2,665
2022-09-30 $2,181
2022-06-30 $2,140
2022-03-31 $2,090
2021-12-31 $2,050
2021-09-30 $2,012
2021-06-30 $1,400
2021-03-31 $1,356
2020-12-31 $1,411
2020-09-30 $1,384
2020-06-30 $1,093
2020-03-31 $988
2019-12-31 $977
2019-09-30 $748
2019-06-30 $733
2019-03-31 $614
2018-12-31 $607
2018-09-30 $600
2018-06-30 $492
2018-03-31 $476
2017-12-31 $473
2017-09-30 $467
2017-06-30 $461
2017-03-31 $456
2016-12-31 $453
2016-09-30 $448
2016-06-30 $445
2016-03-31 $440
2015-12-31 $436
2015-09-30 $433
2015-06-30 $12
2015-03-31 $0
2014-12-31
2014-09-30 $0
2014-06-30 $0
2013-12-31 $3
Sector Industry Market Cap Revenue
Medical Medical Services $21.477B $1.697B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.728B 26.96
Elevance Health (ELV) United States $94.145B 12.15
CVS Health (CVS) United States $81.986B 10.19
Cencora (COR) United States $53.983B 18.77
DiDi Global (DIDIY) China $21.462B 32.57
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.941B 13.70
EUROFINS SCIENT (ERFSF) Luxembourg $12.036B 0.00
Revvity (RVTY) United States $11.610B 19.98
Doximity (DOCS) United States $11.396B 59.26
ICON (ICLR) Ireland $11.324B 10.53
CochLear (CHEOY) Australia $11.195B 0.00
Viatris (VTRS) United States $10.516B 3.61
Medpace Holdings (MEDP) United States $9.017B 23.95
Avantor (AVTR) United States $8.859B 12.87
HealthEquity (HQY) United States $8.361B 41.13
Sonic Healthcare (SKHHY) Australia $8.215B 0.00
Charles River Laboratories (CRL) United States $7.027B 13.77
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
Bausch + Lomb (BLCO) Canada $4.202B 24.77
BrightSpring Health Services (BTSG) United States $3.894B 36.05
Sotera Health (SHC) United States $3.832B 21.77
Surgery Partners (SGRY) United States $2.982B 38.77
Alignment Healthcare (ALHC) United States $2.952B 0.00
Concentras Parent (CON) United States $2.771B 16.01
Organon (OGN) United States $2.264B 2.41
Ardent Health Partners (ARDT) United States $2.121B 9.04
Premier (PINC) United States $2.101B 14.38
Progyny (PGNY) United States $1.886B 41.51
PACS (PACS) United States $1.698B 0.00
GeneDx Holdings (WGS) United States $1.683B 64.83
GoodRx Holdings (GDRX) United States $1.669B 31.07
Teladoc Health (TDOC) United States $1.289B 0.00
Pediatrix Medical (MD) United States $1.234B 9.39
Agilon Health (AGL) United States $1.229B 0.00
Establishment Labs Holdings (ESTA) $1.000B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.911B 14.23
AMN Healthcare Services Inc (AMN) United States $0.866B 8.11
Embecta (EMBC) United States $0.725B 4.89
QDM (QDMI) Hong Kong, SAR China $0.690B 0.00
Nutex Health (NUTX) United States $0.689B 13.50
Enhabit (EHAB) United States $0.530B 43.58
InnovAge Holding (INNV) United States $0.513B 0.00
Auna S.A (AUNA) Luxembourg $0.513B 13.59
Sonida Senior Living (SNDA) United States $0.512B 0.00
LifeMD (LFMD) United States $0.389B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
SBC Medicals (SBC) United States $0.359B 0.00
Beauty Health (SKIN) United States $0.220B 0.00
Performant Healthcare (PHLT) United States $0.202B 0.00
Oncology Institute (TOI) United States $0.193B 0.00
DocGo (DCGO) United States $0.147B 24.08
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.087B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
KindlyMD (KDLY) United States $0.082B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.076B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
Biodesix (BDSX) United States $0.053B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.030B 0.00
ModivCare (MODV) United States $0.018B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00